Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    24516103 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
Conditions: Hypertension;   Diabetes Type 2
Interventions: Drug: Sitagliptin (DPP4 inhibitor);   Drug: Substance P,;   Drug: bradykinin;   Drug: enalaprilat (ACE inhibitor);   Drug: Glucagon-like peptide 1;   Drug: brain natriuretic peptide

Indicates status has not been verified in more than two years